Ok. So Joe can mention the listing and the NGIO IPO because it is public record. The quiet period extends to timeframe, pricing, share structure. The details we want but because they are not complete he can't discuss. They have to hear from the SEC and then Dawson James gets to figure out the rest. Until the rest is figured out there isn't a lot more he can say. I don't recall him saying in the recent interviews any specific details. Perhaps he did and I do not remember.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links